Antibody-drug conjugates in breast cancer: the first-line and curative setting.
PURPOSE OF REVIEW Antibody-drug conjugates (ADCs) have rapidly advanced from later-line salvage therapy into first-line metastatic and curative perioperative settings. This review appraises recent practice-changing data that collectively redefined treatment standards across Human epidermal growth factor receptor 2 (HER...